Nu Skin Enterprises, Inc.
NUS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,732 | $1,969 | $2,226 | $2,696 |
| % Growth | -12% | -11.5% | -17.4% | – |
| Cost of Goods Sold | $550 | $612 | $631 | $675 |
| Gross Profit | $1,182 | $1,357 | $1,595 | $2,020 |
| % Margin | 68.2% | 68.9% | 71.7% | 75% |
| R&D Expenses | $13 | $23 | $0 | $27 |
| G&A Expenses | $479 | $547 | $556 | $666 |
| SG&A Expenses | $1,131 | $1,289 | $1,435 | $1,735 |
| Sales & Mktg Exp. | $652 | $742 | $880 | $1,068 |
| Other Operating Expenses | $189 | -$3 | $48 | $25 |
| Operating Expenses | $1,333 | $1,309 | $1,484 | $1,786 |
| Operating Income | -$152 | $48 | $111 | $234 |
| % Margin | -8.8% | 2.5% | 5% | 8.7% |
| Other Income/Exp. Net | -$23 | -$22 | -$22 | -$2 |
| Pre-Tax Income | -$175 | $27 | $89 | $232 |
| Tax Expense | -$28 | $18 | -$16 | $85 |
| Net Income | -$147 | $9 | $105 | $147 |
| % Margin | -8.5% | 0.4% | 4.7% | 5.5% |
| EPS | -2.95 | 0.17 | 2.1 | 2.93 |
| % Growth | -1,835.3% | -91.9% | -28.3% | – |
| EPS Diluted | -2.95 | 0.17 | 2.07 | 2.86 |
| Weighted Avg Shares Out | 50 | 50 | 50 | 50 |
| Weighted Avg Shares Out Dil | 50 | 50 | 51 | 51 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $10 | $11 |
| Interest Expense | $26 | $26 | $22 | $11 |
| Depreciation & Amortization | $70 | $69 | $73 | $125 |
| EBITDA | -$79 | $203 | $175 | $368 |
| % Margin | -4.6% | 10.3% | 7.9% | 13.7% |